Interaction between alpha₂-and beta₂-adrenergic receptors in rabbit ciliary processes

References

• Waitzman M. B., Woods W. D. Some characteristics of an adenyl cyclase preparation from rabbit ciliary process tissue. Exp. Eye Res 1971; 12: 99–111
   PubMedGoogle Scholar
• Gregory D. S., Bausher L. P., Bromberg B. B., Sears M. L. The beta‐adrenergic receptor and adenyl cyclase of rabbit ciliary processes. New Directions in Ophthalmic Research, M. L. Sears. Yale University Press, New Haven, CT 1981; 127–145
   Google Scholar
• Rodbell M. The role of hormone receptors and GTP‐regulatory proteins in membrane transduction. Nature 1980; 284: 17–22
   PubMed Web of Science ®Google Scholar
• Bylund D. B., U'Prichard D. C. Characterization of alpha1 and alpha2‐adrenergic receptors. Int. Rev. Neurobiol 1983; 24: 343–431
   PubMed Web of Science ®Google Scholar
• Mittag T. W., Tormay A. Adrenergic receptor subtypes in rabbit iris‐ciliary body membranes: classification by radioligand studies. Exp. Eye Res 1985; 40: 239–249
   PubMed Web of Science ®Google Scholar
• Mittag T. W., Tormay A. Drug responces of adenylate cyclase in iris‐ciliary body determined by adenine labelling. Invest. Ophthalmol. Vis. Sci 1985; 26: 396–399
   PubMed Web of Science ®Google Scholar
• Sears M., Gregory D., Bausher L., Mishima H., Stjernschantz J. A receptor for aqueous humor formation. New Directions in Ophthalmic Research, M. L. Sears. Yale University Press, New Haven, CT 1981; 163–183
   Google Scholar
• Sears M. L. Regulation of aqueous flow by the adenylate cyclase receptor complex in the ciliary epithelium. Am. J. Ophthalmol 1985; 100: 194–198
   PubMed Web of Science ®Google Scholar
• Gregory D., Sears M., Bausher L., Mishima H., Mead A. Intraocular pressure and aqueous flow are decreased by cholera toxin. Invest. Ophthalmol. Vis. Sci 1981; 20: 371–381
   PubMed Web of Science ®Google Scholar
• McPhillips J. J. Terbutaline. Pharmacological and Biochemical Properties of Drug Substances, M. E. Goldberg. American Pharmaceutical Association, Washington, D. C. 1977; 311–328
   Google Scholar
• Nathanson J. A. Adrenergic regulation of intraocular pressure: Identification of beta‐adrenergic‐stimulated adenylate cyclase in ciliary process epithelium. Proc. Nat'l. Acad. Sci., U. S. A 1980; 77: 7420–7424
   PubMed Web of Science ®Google Scholar
• Siegl A. M., Daly J. W. Receptor (norepinephrine), P‐site (2′,5′‐dideoxyadenosine), and calcium‐mediated inhibition of prostaglandin and forskolin‐activated cyclic AMP‐generating systems in human platelets. J. Cyclic Nucleotide and Protein Phosphorylation Res 1985; 10: 229–246
   PubMedGoogle Scholar
• Burns T. W., Langley P. E., Terry B. E., Bylund D. B., Forte L. R. Alpha‐2 adrenergic activation inhibits forskolin‐stimulated adenylate cyclase activity and lipolysis in human adipocytes. Life Sci 1982; 31: 815–821
   PubMedGoogle Scholar
• Daiguji M., Meltzer H. Y., U'Prichard D. C. Human platelet alpha.‐adrenergic receptors: labeling with H‐yohimbine, a selective antagonist ligand. Life Sci 1981; 28: 2705–2717
   PubMed Web of Science ®Google Scholar
• Bromberg B. B., Gregory D. S., Sears M. L. Beta‐adrenergic receptors in ciliary processes of the rabbit. Invest. Ophthalmol. Vis. Sci 1980; 19: 203–207
   PubMed Web of Science ®Google Scholar
• DeVries G. W., Mobasser A., Wheeler L. A. Stimulation of endogenous cyclic AMP levels in ciliary body by SK&F 82526, a novel dopamine receptor agonist. Current Eye Res 1986; 5: 449–455
   PubMedGoogle Scholar
• Langham M. E., Diggs E. Beta‐adrenergic responses in the eyes of rabbits, primates, and man. Exp. Eye Res 1974; 19: 281–295
   PubMed Web of Science ®Google Scholar
• U'Prichard D. C., Greenberg D. A., Snyder S. Binding characteristics of a radiolabelled agonist and antagonist at central nervous system alpha noradrenergic receptors. Mol. Pharmacol 1977; 13: 454–473
   PubMed Web of Science ®Google Scholar
• U'Prichard D. C., Mitrius J. C., Kahn D. J., Perry B. D. The alpha ‐adrenergic receptor: multiple affinity states and regulation of a receptor inversely coupled to adenylate cyclase. Molecular Pharmacology of Neurotransmitter Receptors, T. Segawa, H. I. Yamamura, K. Kuriyama. Raven Press, New York, N. Y. 1983; Vol. 36: 53–72
   Google Scholar
• Kahn D. J., Mitrius J. C., U'Prichard D. C. Alpha2‐adrenergic receptors in neuroblastema glioraa hybrid cells. Characterization with agonist and antagonist radioligands and relationship to adenylate cyclase. Mol. Pharm 1982; 21: 17–26
   PubMed Web of Science ®Google Scholar
• Perkins J. P. Desensitization of the response of adenylate cyclase to catecholamines. Current Topics in Membranes and Transport, A. Kleinzeller, B. R. Martin. Academic Press, Inc., New York, N. Y. 1983; Vol. 18: 85–108
   Google Scholar
• Sibley D. R., Lefkowitz R. J. Molecular mechanisms of receptor desensitization using the beta‐adrenergic receptor‐coupled adenylate cyclase system as a model. Nature 1985; 317: 124–129
   PubMed Web of Science ®Google Scholar
• Wax M., Coca‐Prados M., Molinoff P. B. Phorbol esters induce desensitization of adenylate cyclase in rabbit iris/ciliary body and cultured human ciliary epithelial cells. Invest. Ophthalmol. Vis. Sci. (Suppl.) 1986; 27: 288
   Google Scholar
• Jumblatt J., Pon L. Clonidine inhibits adrenergic neurosecretion in the rabbit iris‐ciliary body. Invest. Ophthalmol. Vis. Sci. (Suppl.) 1983; 24: 155
   Google Scholar
• Burke J. A., Potter D. E. Ocular effects of a relatively selective α2 agonist (UK‐14, 304–18) in cats, rabbits and monkeys. Current Eye Res 1986; 5: 665–676
   PubMed Web of Science ®Google Scholar
• Potter D. E. Adrenergic pharmacology of aqueous humor dynamics. Pharmacol. Rev 1981; 33: 133–153
   PubMed Web of Science ®Google Scholar
• Mishima S. Ocular effects of beta‐adrenergic agents. Surv. Ophthalmol 1982; 27: 187–208
   PubMed Web of Science ®Google Scholar
• Sears M. L. Autonomic nervous system: adrenergic agonists. Handbook of Experimental Pharmacology, M. L. Sears. Springer‐Verlag, Berlin, HeidelbergGermany 1984; Vol. 69: 193–248
   Google Scholar
• Bartels S., Lee S., Neufeld A. Forskolin: an experimental drug which stimulates cyclic AMP synthesis in vitro and decreases intraocular pressure after topical administration. Invest. Ophthalmol. Vis. Sci. (Suppl.) 1984; 25: 10
   PubMedGoogle Scholar
• Lee P. ‐Y., Podos S. M., Mittag T., Severin C. Effect of topically applied forskolin on aqueous humor dynamics in cynomolgus monkey. Invest. Ophthalmol. Vis. Sci 1984; 25: 1206–1209
   PubMed Web of Science ®Google Scholar
• Burstein N. L., Sears M. L., Mead A. Aqueous flow in human eyes is reduced by forskolin, a potent adenylate cyclase activator. Exp. Eye Res 1984; 39: 745–749
   PubMed Web of Science ®Google Scholar
• Mittag T., Tormay A., Podos S. M. The VIP‐adenylate cyclase system in rabbit ciliary processes. Invest. Ophthalmol. Vis. Sci. (Suppl.) 1985; 26: 5
   Google Scholar